Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 ASHP Therapeutic Guidelines on the Pharmacologic Management of Nausea and Vomiting in Adult and Pediatric Patients Receiving Chemotherapy or Radiation Therapy or Undergoing Surgery.

× No keyword cloud information.

41 in total

Review 1. Stratified administration of serotonin 5-HT3 receptor antagonists (setrons) for chemotherapy-induced emesis. Economic implications.

Authors: L A Sanchez; M Holdsworth; S B Bartel
Journal: Pharmacoeconomics Date: 2000-12 Impact factor: 4.981

2. The importance of clinical practice guidelines (CPGs) for the quality and development of supportive care in Central and Eastern European (CEE) countries.

Authors: Snezana Bosnjak
Journal: Support Care Cancer Date: 2003-10-15 Impact factor: 3.603

3. Stability of an extemporaneous oral liquid aprepitant formulation.

Authors: L Lee Dupuis; Karen Lingertat-Walsh; Scott E Walker
Journal: Support Care Cancer Date: 2008-11-29 Impact factor: 3.603

4. A prospective study of gastrointestinal radiation therapy-induced nausea and vomiting.

Authors: Michael Poon; Kristopher Dennis; Carlo DeAngelis; Hans Chung; Jordan Stinson; Liying Zhang; Gillian Bedard; Marko Popovic; Nicholas Lao; Natalie Pulenzas; Shun Wong; Edward Chow
Journal: Support Care Cancer Date: 2014-01-12 Impact factor: 3.603

5. A double-blind, crossover, randomized dose-comparison trial of granisetron for the prevention of acute and delayed nausea and emesis in children receiving moderately emetogenic carboplatin-based chemotherapy.

Authors: Su G Berrak; Nihal Ozdemir; Nadi Bakirci; Emine Turkkan; Cengiz Canpolat; Bahar Beker; Asim Yoruk
Journal: Support Care Cancer Date: 2007-03-20 Impact factor: 3.603

Review 6. Serotonin type 3-receptor antagonists for chemotherapy-induced nausea and vomiting: therapeutically equivalent or meaningfully different?

Authors: Jill M Kolesar; Jens Eickhoff; Lee C Vermeulen
Journal: Am J Health Syst Pharm Date: 2014-03-15 Impact factor: 2.637

7. Randomized double-blind study of the Reliefband as an adjunct to standard antiemetics in patients receiving moderately-high to highly emetogenic chemotherapy.

Authors: Imad Treish; Stacy Shord; John Valgus; Donald Harvey; Jessica Nagy; Jennifer Stegal; Celeste Lindley
Journal: Support Care Cancer Date: 2003-06-27 Impact factor: 3.603

8. Outcomes Associated with 5-HT3-RA Therapy Selection in Patients with Chemotherapy-Induced Nausea and Vomiting: A Retrospective Claims Analysis.

Authors: Claudio Faria; Xuan Li; Norman Nagl; Ali McBride
Journal: Am Health Drug Benefits Date: 2014-01

9. Chemotherapy-induced nausea and vomiting in routine practice: a European perspective.

Authors: Agnes Glaus; Cornelia Knipping; Rudolf Morant; Christel Böhme; Burkhard Lebert; Frank Beldermann; Bernhard Glawogger; Paz Fernandez Ortega; André Hüsler; Robert Deuson
Journal: Support Care Cancer Date: 2004-10 Impact factor: 3.603

10. Insight in the prediction of chemotherapy-induced nausea.

Authors: Joseph A Roscoe; Gary R Morrow; Ben Colagiuri; Charles E Heckler; Bryan D Pudlo; Lauren Colman; Karen Hoelzer; Andrew Jacobs
Journal: Support Care Cancer Date: 2009-08-23 Impact factor: 3.603